NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8+ T cells

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 268-278

  Whitman, Emily ^a   Barber, Amorette ^a  

^a LONGWOOD UNIVERSITY   (United States)

Author keywords

CD8T cell; Costimulation; Cytokine; DAP10; Immunotherapy; NF B

Indexed keywords

ALPHA INTERFERON; CD28 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LYMPHOTOXIN; LYMPHOTOXIN BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CD3 ANTIGEN; CYTOKINE; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA BINDING; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOTOXICITY; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MURINAE;

ANIMALS; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; HUMANS; INFLAMMATION MEDIATORS; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED C57BL; NF-KAPPA B; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 84912035239     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.07.015     Document Type: Article

References (50)

1. Balachandran S., Beg A.A. Defining emerging roles for NF-κB in antivirus responses: revisiting the interferon-β enhanceosome paradigm. PLoS Pathog. 2011, 7:e1002165.
2. Barber A., Sentman C.L. NKG2D receptor regulates human effector T-cell cytokine production. Blood 2011, 117:6571-6581.
3. Blackwell T.S., Christman J.W. The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. 1997, 17:3-9.
4. Capece D., Verzella D., Fischietti M., Zazzeroni F., Alesse E. Targeting costimulatory molecules to improve antitumor immunity. J. Biomed. Biotechnol. 2012, 2012:e926321.
5. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 2011, 235:267-285.
6. Cheng J., Montecalvo A., Kane L.P. Regulation of NF-κB induction by TCR/CD28. Immunol. Res. 2011, 50:113-117.
7. Chu T., Tyznik A.J., Roepke S., Berkley A.M., Woodward-Davis A., Pattacini L., Bevan M.J., Zehn D., Prlic M. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep. 2013, 3:701-708.
8. Clark R.B. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 2002, 71:388-400.
9. Deng J., Xia W., Miller S.A., Wen Y., Wang H.Y., Hung M.C. Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway. Mol. Carcinog. 2004, 39:139-146.
10. Dobrzanski M.J., Reome J.B., Hollenbaugh J.A., Hylind J.C., Dutton R.W. Effector cell-derived lymphotoxin alpha and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases. Cancer Res. 2004, 64:406-414.
11. Du Q., Gellar D.A. Cross-regulation between Wnt and NF-κB signaling pathways. Immunopathol. Dis. Ther. 2010, 1:155-181.
12. + T cells. J. Immunol. 2005, 174:1922-1931.
13. + T cells. J. Immunol. 2005, 175:7093-7097.
14. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001, 2:255-260.
15. Gurevich I., Zhang C., Encarnacao P.C., Struzynski C.P., Livings S.E., Aneskievich B.J. PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1. Biochim. Biophys. Acta 2012, 1819:1-15.
16. Harhaj E.W., Maggirwar S.B., Good L., Sun S.C. CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol. Cell. Biol. 1996, 16:6736-6743.
17. Hessmann M., Rausch A., Rückerl D., Adams P.S., Simon M., Gilfillan S., Colonna M., Ehlers S., Hölscher C. DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection. Immunobiology 2011, 216:639-647.
18. Kane L.P., Lin J., Weiss A. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol. 2002, 23:413-420.
19. Kane L.P., Andres P.G., Howland K.C., Abbas A.K., Weiss A. Akt provides the CD28 costimulatory signal for upregulation of IL-2 and IFN-γ but not Th2 cytokines. Nat. Immunol. 2001, 2:37-44.
20. Kane L.P., Shapiro V.S., Stokoe D., Weiss A. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 1999, 9:601-604.
21. Kasibhatla S., Genestier L., Green D.R. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 1999, 274:987-992.
22. Lai J.-H., Tan T.-H. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 1994, 269:30077-30080.
23. Lanier L.L. DAP10-and DAP12-associated receptors in innate immunity. Immunol. Rev. 2009, 227:150-160.
24. Lee H.W., Choi H.J., Ha S.J., Lee K.T., Kwon Y.G. Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim. Biophys. Acta 2013, 1835:170-179.
25. + T cells. J. Immunol. 2005, 174:4480-4484.
26. + CTL function: similarities and differences between NKG2D and CD28 costimulation. J. Immunol. 2005, 175:2825-2833.
27. Merika M., Williams A.J., Chen G., Collins T., Thanos D. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1998, 1:277-287.
28. Mistry A.R., O'Callaghan C.A. Regulation of ligands for the activating receptor NKG2D. Immunology 2007, 121:439-447.
29. + T cells mediate inflammation and airway hyper-responsiveness. Nat. Med. 2004, 10:865-869.
30. Natarajan K., Singh S., Burke T.R., Grunberger D., Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Nat. Acad. Sci. U.S.A. 1996, 93:9090-9095.
31. Ogasawara K., Lanier L.L. NKG2D in NK and T cell-mediated immunity. J. Clin. Immunol. 2005, 25:534-540.
32. + T cells. PLoS One 2010, 5:e12635.
33. Raulet D.H. Roles of NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003, 3:781-790.
34. Sanda T., Iida S., Ogura H., Asamitsu K., Murata T., Bacon K.B., Ueda R., Okamoto T. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor. Clin. Cancer Res. 2005, 11:1974-1982.
35. Sharpe A., Abbas A. T-cell costimulation-biology, therapeutic potential, and challenges. N. Engl. J. Med. 2006, 355:973-975.
36. Shrikant P.A., Rao R., Li Q., Kesterson J., Eppolito C., Mischo A., Singhal P. Regulating functional cell fates in CD8 T cells. Immunol. Res. 2010, 46:12-22.
37. Straus D.S., Glass C.K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 2007, 28:551-558.
38. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., Ernst M., Saris C.J., O'Shea J.J., Hunter C.A. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
39. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009, 15:277-284.
40. Tuosto L. NF-κB family of transcription factors: biochemical players of CD28 co-stimulation. Immunol. Lett. 2011, 135:1-9.
41. Ullrich E., Koch J., Cerwenka A., Steinle A. New prospects on the NKG2D/NKG2DL system for oncology. Oncoimmunology 2013, 2:e26097.
42. Upadhyay V., Fu Y.X. Lymphotoxin signalling in immune homeostasis and the control of microorganisms. Nat. Rev. Immunol. 2013, 13:270-279.
43. Upshaw J.L., Leibson P.J. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes. Semin. Immunol. 2006, 18:167-175.
44. Ware C.F. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 2005, 23:787-819.
45. Watts T. Staying alive: T cell costimulation, CD28, and Bcl-xL. J. Immunol. 2010, 185:3785-3787.
46. Welsh R.M., Bahl K., Marshall H.D., Urban S.L. Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog. 2012, 8:e1002352.
47. Wensveen F.M., Lenartic M., Jelencic V., Lemmermann N.A., ten Brinke A., Jonjic S., Polic B. NKG2D induces Mcl-1 expression and mediates survival of CD8 memory T cell precursors via phosphatidylinositol 3-kinase. J. Immunol. 2013, 191:1307-1315.
48. Zhang T., Lemoi B.A., Sentman C.L. Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy. Blood 2005, 106:1544-1551.
49. Zhang T., Barber A., Sentman C.L. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways. Can. Res. 2007, 67:11029-11036.
50. + T cell memory recall but not effector responses. Nat. Med. 2012, 18:422-428.